Proteomics Market Report 2026

The proteomics market size has grown rapidly in recent years. It will grow from $39.37 billion in 2025 to $44.65 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to expansion of life sciences research funding, increasing use of proteomics in drug discovery, availability of high-performance analytical instruments, growth of academic research programs, rising demand for biomarker discovery.

The proteomics market size is expected to see rapid growth in the next few years. It will grow to $73.33 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing investments in precision medicine initiatives, growing demand for multi-omics analysis, expansion of clinical proteomics applications, rising adoption of AI-driven data analysis tools, increasing focus on disease pathway analysis. Major trends in the forecast period include increasing adoption of advanced proteomic analysis techniques, rising use of mass spectrometry-based proteomics, growing integration of proteomics with genomics data, expansion of cloud-based proteomics platforms, enhanced focus on quantitative proteomics.

The expansion of the pharmaceutical industry is expected to drive the growth of the proteomics market in the coming years. The pharmaceutical industry focuses on the research, development, manufacturing, and distribution of drugs and medications for medical applications. Growth in this industry is being fueled by the increasing global burden of chronic diseases, which is driving the need for continuous drug development and more advanced therapeutic solutions, thereby supporting sustained market expansion. Proteomics plays an essential role in drug development by enabling the identification, characterization, and monitoring of proteins for drug target discovery and biomarker identification. For example, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade association representing the pharmaceutical industry in Europe, total pharmaceutical production in Europe reached €390.0 billion ($422,803 million) in 2023, compared with €363.3 billion ($393,857 million) in 2022. Therefore, the growing pharmaceutical industry is contributing to the growth of the proteomics market.

Major companies operating in the proteomics market are concentrating on the development of accurate quantitative analysis kits to strengthen their competitive position. Precise quantitative analysis kits are designed to accurately measure protein expression levels and identify biomarkers across a wide range of biological samples. For instance, in January 2023, SCIEX, a US-based mass spectrometry instrumentation manufacturer, launched the Fast Glycan Labeling and Analysis kit, along with an updated version of the Biologics Explorer software, aimed at improving key workflows for protein therapeutic analysis. These solutions are intended to accelerate the detection and characterization of glycans associated with proteins, providing researchers with advanced tools for detailed biopharmaceutical analysis. The software enables researchers to select the most appropriate analytical methods and tools for their specific applications, thereby improving the efficiency and effectiveness of protein characterization studies.

In July 2024, Thermo Fisher Scientific, a US-based life science and clinical research company, acquired Olink Holding for approximately $3.1 billion. This acquisition supports Thermo Fisher’s strategy to strengthen its portfolio of innovative technologies by incorporating Olink’s proprietary Proximity Extension Assay technology, which enables high-throughput protein analysis using quantitative polymerase chain reaction and next-generation sequencing readout systems. The PEA platform includes a library of more than 5,300 validated protein biomarker targets, significantly enhancing Thermo Fisher’s proteomics research capabilities. Olink Holding is a Sweden-based provider of next-generation proteomics solutions.

Major companies operating in the proteomics market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, Bio-Rad Laboratories Inc., Promega Corporation, Waters Corporation, Creative Proteomics, Sino Biological, EIAab, DIMA Biotechnology, GE Healthcare, Perseus Proteomics Inc., JEOL, APTBIO, Vproteomics, Shimadzu Corporation, Abcam plc, MRM Proteomics Inc., Biognosys AG, Olink Proteomics, Horiba, MS Bioworks, LC Sciences, MtoZ Biolabs, Integrated Proteomics Applications, Quantumbio Inc., Luminex Corporation, Applied Biomics Inc., Isoplexis Corporation, Caprion Proteomics Inc.

North America was the largest region in the proteomics market in 2025. Western Europe was the second largest region in the global proteomics market share. The regions covered in the proteomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the proteomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the proteomics market by increasing costs of imported mass spectrometers, chromatography systems, reagents, and advanced software tools. Research laboratories and pharmaceutical companies in North America and Europe are most affected due to dependence on imported analytical platforms, while Asia-Pacific faces higher costs for export-oriented instrument manufacturing. These tariffs are increasing capital expenditure and delaying equipment upgrades. However, they are also driving domestic instrument assembly, regional reagent production, and localized development of proteomics software solutions.

The proteomics market research report is one of a series of new reports that provides proteomics market statistics, including proteomics industry global market size, regional shares, competitors with a proteomics market share, detailed proteomics market segments, market trends and opportunities, and any further data you may need to thrive in the proteomics industry. This proteomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Proteomics is the scientific study of the structure and functions of proteins and their roles in drug discovery, disease diagnosis, and treatment. It is used to assess protein expression levels, understand the involvement of proteins in metabolic pathways, and analyze protein modifications.

The main types of proteomics include protein microarrays, spectroscopy, X-ray crystallography, chromatography, electrophoresis, surface plasmon resonance, and protein fractionation. The key components involved include reagents, instruments, and software, which are used to support proteomic analytical services and instrument-related services.

The proteomics market consists of sales of proteins that are used for drug discovery, clinical diagnosis, molecular medicine and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.